Some Cancer Patients ‘Hyperprogress’ on Immunotherapy – Medscape
Medscape |
Some Cancer Patients 'Hyperprogress' on Immunotherapy
Medscape LA JOLLA, California — When it comes to immunotherapy for cancer, "everyone likes to talk about the 'super-responders'," said an expert here at the 10th Future of Genomic Medicine Conference. But evidence is emerging that some patients become … |
